Your browser doesn't support javascript.
loading
Insertional Mutagenesis Identifies a STAT3/Arid1b/ß-catenin Pathway Driving Neurofibroma Initiation.
Wu, Jianqiang; Keng, Vincent W; Patmore, Deanna M; Kendall, Jed J; Patel, Ami V; Jousma, Edwin; Jessen, Walter J; Choi, Kwangmin; Tschida, Barbara R; Silverstein, Kevin A T; Fan, Danhua; Schwartz, Eric B; Fuchs, James R; Zou, Yuanshu; Kim, Mi-Ok; Dombi, Eva; Levy, David E; Huang, Gang; Cancelas, Jose A; Stemmer-Rachamimov, Anat O; Spinner, Robert J; Largaespada, David A; Ratner, Nancy.
Afiliação
  • Wu J; Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital University of Cincinnati, Cincinnati, OH 45229, USA.
  • Keng VW; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; Department of Pediatrics, Cell Biology and Development, University of Minnesota, Minneapolis, MN 55455, USA; Center for Genome Engineering, University of Minnesota, Minneapolis, MN 55455, USA.
  • Patmore DM; Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital University of Cincinnati, Cincinnati, OH 45229, USA.
  • Kendall JJ; Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital University of Cincinnati, Cincinnati, OH 45229, USA.
  • Patel AV; Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital University of Cincinnati, Cincinnati, OH 45229, USA.
  • Jousma E; Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital University of Cincinnati, Cincinnati, OH 45229, USA.
  • Jessen WJ; Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital University of Cincinnati, Cincinnati, OH 45229, USA.
  • Choi K; Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital University of Cincinnati, Cincinnati, OH 45229, USA.
  • Tschida BR; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; Center for Genome Engineering, University of Minnesota, Minneapolis, MN 55455, USA.
  • Silverstein KA; Biostatistics and Informatics, University of Minnesota, Minneapolis, MN 55455, USA.
  • Fan D; Biostatistics and Informatics, University of Minnesota, Minneapolis, MN 55455, USA.
  • Schwartz EB; Ohio State University, College of Pharmacy, Columbus, OH 43210, USA.
  • Fuchs JR; Ohio State University, College of Pharmacy, Columbus, OH 43210, USA.
  • Zou Y; Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Research Foundation, Cincinnati Children's Hospital University of Cincinnati, Cincinnati, OH 45229, USA.
  • Kim MO; Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Research Foundation, Cincinnati Children's Hospital University of Cincinnati, Cincinnati, OH 45229, USA.
  • Dombi E; Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA.
  • Levy DE; Department of Pathology and New York University Cancer Institute, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA.
  • Huang G; Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital University of Cincinnati, Cincinnati, OH 45229, USA.
  • Cancelas JA; Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital University of Cincinnati, Cincinnati, OH 45229, USA; Hoxworth Blood Center, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.
  • Stemmer-Rachamimov AO; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.
  • Spinner RJ; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
  • Largaespada DA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; Department of Pediatrics, Cell Biology and Development, University of Minnesota, Minneapolis, MN 55455, USA; Center for Genome Engineering, University of Minnesota, Minneapolis, MN 55455, USA.
  • Ratner N; Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital University of Cincinnati, Cincinnati, OH 45229, USA. Electronic address: nancy.ratner@cchmc.org.
Cell Rep ; 14(8): 1979-90, 2016 Mar 01.
Article em En | MEDLINE | ID: mdl-26904939
ABSTRACT
To identify genes and signaling pathways that initiate Neurofibromatosis type 1 (NF1) neurofibromas, we used unbiased insertional mutagenesis screening, mouse models, and molecular analyses. We mapped an Nf1-Stat3-Arid1b/ß-catenin pathway that becomes active in the context of Nf1 loss. Genetic deletion of Stat3 in Schwann cell progenitors (SCPs) and Schwann cells (SCs) prevents neurofibroma formation, decreasing SCP self-renewal and ß-catenin activity. ß-catenin expression rescues effects of Stat3 loss in SCPs. Importantly, P-STAT3 and ß-catenin expression correlate in human neurofibromas. Mechanistically, P-Stat3 represses Gsk3ß and the SWI/SNF gene Arid1b to increase ß-catenin. Knockdown of Arid1b or Gsk3ß in Stat3(fl/fl);Nf1(fl/fl);DhhCre SCPs rescues neurofibroma formation after in vivo transplantation. Stat3 represses Arid1b through histone modification in a Brg1-dependent manner, indicating that epigenetic modification plays a role in early tumorigenesis. Our data map a neural tumorigenesis pathway and support testing JAK/STAT and Wnt/ß-catenin pathway inhibitors in neurofibroma therapeutic trials.
Assuntos
Carcinogênese/genética; Proteínas de Ligação a DNA/genética; Regulação Neoplásica da Expressão Gênica; Acetiltransferase N-Terminal A/genética; Neurofibromatose 1/genética; Neoplasias do Sistema Nervoso Periférico/genética; Fator de Transcrição STAT3/genética; beta Catenina/genética; Animais; Carcinogênese/metabolismo; Carcinogênese/patologia; DNA Helicases/genética; DNA Helicases/metabolismo; Proteínas de Ligação a DNA/antagonistas & inibidores; Proteínas de Ligação a DNA/metabolismo; Modelos Animais de Doenças; Feminino; Glicogênio Sintase Quinase 3 beta/antagonistas & inibidores; Glicogênio Sintase Quinase 3 beta/genética; Glicogênio Sintase Quinase 3 beta/metabolismo; Histonas/genética; Histonas/metabolismo; Humanos; Camundongos; Camundongos Nus; Mutagênese Insercional; Acetiltransferase N-Terminal A/antagonistas & inibidores; Acetiltransferase N-Terminal A/metabolismo; Transplante de Neoplasias; Células-Tronco Neurais/metabolismo; Células-Tronco Neurais/patologia; Neurofibromatose 1/metabolismo; Neurofibromatose 1/patologia; Neurofibromina 1/genética; Neurofibromina 1/metabolismo; Proteínas Nucleares/genética; Proteínas Nucleares/metabolismo; Neoplasias do Sistema Nervoso Periférico/metabolismo; Neoplasias do Sistema Nervoso Periférico/patologia; Fosforilação; RNA Interferente Pequeno/genética; RNA Interferente Pequeno/metabolismo; Fator de Transcrição STAT3/antagonistas & inibidores; Fator de Transcrição STAT3/metabolismo; Células de Schwann/metabolismo; Células de Schwann/patologia; Transdução de Sinais; Fatores de Transcrição/genética; Fatores de Transcrição/metabolismo; beta Catenina/metabolismo

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias do Sistema Nervoso Periférico / Regulação Neoplásica da Expressão Gênica / Neurofibromatose 1 / Proteínas de Ligação a DNA / Fator de Transcrição STAT3 / Beta Catenina / Acetiltransferase N-Terminal A / Carcinogênese Tipo de estudo: Prognostic_studies Idioma: En Revista: Cell Rep Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias do Sistema Nervoso Periférico / Regulação Neoplásica da Expressão Gênica / Neurofibromatose 1 / Proteínas de Ligação a DNA / Fator de Transcrição STAT3 / Beta Catenina / Acetiltransferase N-Terminal A / Carcinogênese Tipo de estudo: Prognostic_studies Idioma: En Revista: Cell Rep Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos